ArticleOncology letters2024

The inhibitory effect of trastuzumab on BT474 triple‑positive breast cancer cell viability is reversed by the combination of progesterone and estradiol.

José A López-Méndez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.